HomeProductsBioactive CompoundsTransporters & Ion ChannelsSGLTErtugliflozin
Chemical structure of CAS 1210344-57-2

Ertugliflozin

CAS No.1210344-57-2
MDL No.MFCD21609259
MFC22H25ClO7
MW436.90
InChI KeyMCIACXAZCBVDEE-CUUWFGFTSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Ertugliflozin is a diarylmethane compound.

CAS No.1210344-57-2
Product NameErtugliflozin

Biological Targets

SLC5A2

Associated Conditions

type 2 diabetes mellitus·Mitral regurgitation·heart failure·diabetes mellitus
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Environmental Risk Factors for Developing Type 2 Diabetes Mellitus: A Systematic Review.

International journal of environmental research and public health • Vol. 15, Issue 1 • 2018
PMID: 29304014PMC: PMC5800177DOI: 10.3390/ijerph15010078

Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date.

Drug design, development and therapy • Vol. 11 • 2017
PMID: 29042751PMC: PMC5633300DOI: 10.2147/DDDT.S114932

Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects.

Drug metabolism and disposition: the biological fate of chemicals • Vol. 41, Issue 2 • 2013
PMID: 23169609DOI: 10.1124/dmd.112.049551

Preclinical species and human disposition of PF-04971729, a selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type 2 diabetes mellitus.

Drug metabolism and disposition: the biological fate of chemicals • Vol. 39, Issue 9 • 2011
PMID: 21690265DOI: 10.1124/dmd.111.040675

Documentation

Similar Products